ADAPTIMMUNE THERAPEUTICS-ADR (ADAP)
US00653A1079 - ADR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.15M 55.30% | 27.15M 341.46% | 60.281M 122.03% | 183.8M 204.91% | 40.121M -78.17% | 62.936M 56.87% | 145.84M 131.73% | 230.47M 58.03% | 308.6M 33.90% | 384.88M 24.72% | 446.95M 16.13% | |
| EBITDA YoY % growth | -155.68M -23.74% | -155.59M 0.06% | -120.852M 22.33% | -34.986M 71.05% | -131.376M -275.51% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -162.25M -21.62% | -161.67M 0.36% | -130.692M 19.16% | -56.493M 56.77% | -148.093M -162.15% | -135.308M 8.63% | -98.855M 26.94% | -43.338M 56.16% | 27.501M 163.46% | 85.11M 209.48% | 128.97M 51.53% | |
| Operating Margin | -2,638.21% | -595.47% | -216.80% | -30.74% | -369.12% | -214.99% | -67.78% | -18.80% | 8.91% | 22.11% | 28.86% | |
| EPS YoY % growth | -1.02 -6.25% | -1.00 1.96% | -0.66 33.60% | -0.16 75.42% | -0.44 -170.00% | -0.35 20.53% | -0.82 -133.01% | -0.60 26.25% | 0.58 196.61% | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.15 37.53% | -0.16 13.02% | -0.14 -159.50% | -0.13 -1,205.60% | -0.12 17.01% |
| Revenue Q2Q % growth | 5.498M 2,280.09% | 8.874M 56.29% | 7.718M -93.98% | 9.35M -77.14% | 11.254M 104.69% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -45.353M 9.03% | -39.542M 12.49% | -38.505M -153.63% | -35.7M -143.19% | -33.303M 26.57% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.01 95.00% | -0.13 | 0.12 | 92.37% |
| Q2 2024 Q2Q % growth | 0.24 204.35% | -0.07 | 0.31 | 428.30% |
| Q1 2024 Q2Q % growth | -0.18 -3,100.00% | -0.10 | -0.08 | -80.07% |
| Q4 2023 Q2Q % growth | -0.24 -33.33% | -0.10 | -0.14 | -135.29% |
| Q3 2023 Q2Q % growth | -0.20 16.67% | -0.14 | -0.06 | -42.60% |
| Q2 2023 Q2Q % growth | -0.23 17.86% | -0.14 | -0.09 | -69.36% |
| Q1 2023 Q2Q % growth | 0.01 102.00% | -0.15 | 0.15 | 104.05% |
| Q4 2022 Q2Q % growth | -0.18 25.00% | -0.25 | 0.07 | 28.94% |
| Q3 2022 Q2Q % growth | -0.24 20.00% | -0.25 | 0.01 | 2.64% |
| Q2 2022 Q2Q % growth | -0.28 -16.67% | -0.25 | -0.03 | -11.97% |
| Q1 2022 Q2Q % growth | -0.30 -25.00% | -0.22 | -0.08 | -34.10% |
| Q4 2021 Q2Q % growth | -0.24 | 0.14 | -0.38 | -268.07% |
| Q3 2021 Q2Q % growth | -0.30 -25.00% | -0.27 | -0.03 | -10.99% |
| Q2 2021 Q2Q % growth | -0.24 | -0.25 | 0.01 | 3.88% |
| Q1 2021 Q2Q % growth | -0.24 | -0.26 | 0.02 | 5.88% |
| Q4 2020 Q2Q % growth | -0.24 20.00% | -0.24 | 0.00 | -1.28% |
| Q3 2020 Q2Q % growth | -0.24 33.33% | -0.26 | 0.02 | 7.36% |
| Q2 2020 Q2Q % growth | -0.24 38.46% | -0.24 | 0.00 | 0.02% |
| Q1 2020 Q2Q % growth | -0.24 7.69% | -0.26 | 0.02 | 7.12% |
| Q4 2019 Q2Q % growth | -0.30 16.67% | -0.35 | 0.05 | 13.58% |
| Q3 2019 Q2Q % growth | -0.36 -700.00% | -0.31 | -0.05 | -15.53% |
| Q2 2019 Q2Q % growth | -0.39 18.75% | -0.36 | -0.03 | -8.62% |
| Q1 2019 Q2Q % growth | -0.26 -18.18% | -0.32 | 0.06 | 18.56% |
| Q4 2018 Q2Q % growth | -0.36 | -0.33 | -0.03 | -9.38% |
| Q3 2018 Q2Q % growth | 0.06 | -0.06 | 0.12 | 206.95% |
| Q2 2018 Q2Q % growth | -0.48 | -0.28 | -0.20 | -72.17% |
| Q1 2018 Q2Q % growth | -0.22 | -0.25 | 0.03 | 10.75% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 40.901M 458.83% | 11.396M | 29.505M | 258.91% |
| Q2 2024 Q2Q % growth | 128.231M 2,399.63% | 46.224M | 82.007M | 177.41% |
| Q1 2024 Q2Q % growth | 5.678M -88.07% | 9.367M | -3.689M | -39.38% |
| Q4 2023 Q2Q % growth | 231K -97.91% | 20.876M | -20.645M | -98.89% |
| Q3 2023 Q2Q % growth | 7.319M 4.41% | 10.489M | -3.17M | -30.22% |
| Q2 2023 Q2Q % growth | 5.13M -7.40% | 8.957M | -3.827M | -42.73% |
| Q1 2023 Q2Q % growth | 47.601M 1,229.64% | 5.027M | 42.574M | 846.91% |
| Q4 2022 Q2Q % growth | 11.03M 676.76% | 4.208M | 6.822M | 162.12% |
| Q3 2022 Q2Q % growth | 7.01M 484.17% | 4.118M | 2.892M | 70.23% |
| Q2 2022 Q2Q % growth | 5.54M 78.71% | 6.286M | -746K | -11.87% |
| Q1 2022 Q2Q % growth | 3.58M 732.56% | 3.351M | 229K | 6.83% |
| Q4 2021 Q2Q % growth | 1.42M -5.33% | 98.379M | -96.959M | -98.56% |
| Q3 2021 Q2Q % growth | 1.2M 0.84% | 1.399M | -199K | -14.22% |
| Q2 2021 Q2Q % growth | 3.1M 520.00% | 1.384M | 1.716M | 123.99% |
| Q1 2021 Q2Q % growth | 430K -43.42% | 1.87M | -1.44M | -77.01% |
| Q4 2020 Q2Q % growth | 1.5M 105.48% | 2.023M | -523K | -25.85% |
| Q3 2020 Q2Q % growth | 1.19M 395.83% | 888.859K | 301.141K | 33.88% |
| Q2 2020 Q2Q % growth | 500K 212.50% | 951.997K | -451.997K | -47.48% |
| Q1 2020 Q2Q % growth | 760K | 23.751M | -22.991M | -96.80% |
| Q4 2019 Q2Q % growth | 730K -50.68% | 1.55M | -820K | -52.90% |
| Q3 2019 Q2Q % growth | 240K -99.41% | 1.51M | -1.27M | -84.11% |
| Q2 2019 Q2Q % growth | 160K -98.23% | 2.04M | -1.88M | -92.16% |
| Q1 2019 Q2Q % growth | -100.00% | 2.037M | -2.037M | -100.00% |
| Q4 2018 Q2Q % growth | 1.48M | 5.836M | -4.356M | -74.64% |
| Q3 2018 Q2Q % growth | 40.79M | 33.688M | 7.102M | 21.08% |
| Q2 2018 Q2Q % growth | 9.04M | 8.884M | 156K | 1.76% |
| Q1 2018 Q2Q % growth | 8.2M | 9.285M | -1.085M | -11.69% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -16.67% | -14.84% | 58.97% | 64.91% |
| Revenue | -51.7% | -61.07% | 8.83% | 12.01% |